Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,280
Closed -$244K 479
2021
Q1
$244K Sell
3,280
-319
-9% -$24.2K 0.01% 429
2020
Q4
$262K Buy
3,599
+350
+11% +$24.7K 0.01% 406
2020
Q3
$216K Buy
+3,249
New +$206K 0.01% 416
2019
Q2
Sell
-4,461
Closed -$216K 505
2019
Q1
$216K Buy
+4,461
New +$201K 0.01% 503
2018
Q3
Sell
-5,151
Closed -$205K 582
2018
Q2
$205K Sell
5,151
-7,175
-58% -$276K 0.01% 559
2018
Q1
$460K Buy
12,326
+7,235
+142% +$292K 0.01% 405
2017
Q4
$218K Buy
+5,091
New +$203K 0.01% 568
2017
Q3
Sell
-4,831
Closed -$219K 601
2017
Q2
$219K Sell
4,831
-10
-0.2% -$441 0.01% 562
2017
Q1
$206K Sell
4,841
-459
-9% -$18.7K 0.01% 581
2016
Q4
$213K Buy
5,300
+60
+1% +$2.31K 0.01% 552
2016
Q3
$203K Buy
+5,240
New +$198K 0.01% 574
2016
Q2
Sell
-10,276
Closed -$355K 572
2016
Q1
$355K Hold
10,276
0.01% 434
2015
Q4
$398K Buy
+10,276
New +$400K 0.02% 414

Other funds holding HOLX

Conning Inc's HOLX Position: Q2 2021 in Review

Conning Inc sold out of Hologic (HOLX) in Q2 2021, closing a stake of 3,280 shares — an estimated $244K sold.

Conning Inc first reported a position in HOLX in Q4 2015 and held it in 13 quarters. The position peaked at $460K in Q1 2018. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

  • Conning Inc reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
  • Conning Inc sold 3,280 Hologic shares in Q2 2021, an estimated $244K.
  • Conning Inc first reported a position in Hologic in Q4 2015 and held it in 13 quarters.
  • Conning Inc's Hologic position peaked at $460K in Q1 2018.
  • 625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Conning Inc's 13F filing for Q2 2021, filed 29 Jul 2021.